American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 289-295, August 2007

Treatment of Dialysis Catheter–Related Staphylococcus aureus Bacteremia With an Antibiotic Lock: A Quality Improvement Report

Portions of this manuscript were presented in abstract form at the American Society of Nephrology Meeting, San Diego, CA, on November 15-19, 2006.

Division of Nephrology, University of Alabama at Birmingham, AL.

Received 24 January 2007; accepted 9 April 2007. published online 16 June 2007.

Background

Dialysis catheter–related bacteremia is often treated successfully by instilling an antibiotic-heparin solution into the catheter lumen (an antibiotic lock) in conjunction with systemic antibiotic therapy without removal of the catheter. The efficacy of this therapy is uncertain in Staphylococcus aureus bacteremia.

Design

Quality improvement report.

Setting & Participants

113 catheter-dependent hemodialysis outpatients with S aureus catheter-related bacteremia treated with a standardized antibiotic lock protocol. Data for all patients with catheter-related bacteremia are recorded in a prospective database.

Quality Improvement Plan

In conjunction with systemic antibiotic therapy (vancomycin for methicillin-resistant S aureus or cefazolin for methicillin-sensitive S aureus), an antibiotic lock was instilled into each catheter lumen after each dialysis session for 3 weeks.

Measures

Treatment failure is defined as persistent fever after 48 hours of antibiotic therapy or recurrent S aureus bacteremia within 90 days. Clinical cure is defined as resolution of fever and no recurrence of bacteremia. Major infection-related complications within 6 months were documented.

Results

The catheter could not be salvaged in 67 patients (59%) because of persistent fever in 40 patients and recurrent bacteremia in 27 patients. A clinical cure was achieved in 46 patients (41%). A serious complication of catheter-related bacteremia occurred in 9.7% of all patients (11 of 113 patients). Serious complications were observed in 25% of patients (10 of 40 patients) with persistent fever, but only 1.4% of all other patients (1 of 73 patients; P < 0.0001).

Limitations

This was a single-center study. Serum antibiotic levels were not measured.

Conclusions

Routine antibiotic lock therapy is not appropriate for patients with S aureus catheter-related bacteremia. Serious complications occur primarily in patients with persistent fever.

Index Words: Arteriovenous access, dialysis catheter, infection, antibiotic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2007.04.014 on June 13, 2007.

PII: S0272-6386(07)00737-8

doi:10.1053/j.ajkd.2007.04.014

American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 289-295, August 2007